A phase I/II, open-label pilot trial to evaluate the safety of Rapamune (sirolimus) in patients with multiple sclerosis

Trial Profile

A phase I/II, open-label pilot trial to evaluate the safety of Rapamune (sirolimus) in patients with multiple sclerosis

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 29 Sep 2016

At a glance

  • Drugs Sirolimus (Primary)
  • Indications Multiple sclerosis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 17 Jan 2013 Actual initiation date May 2003 added as reported by ClinicalTrials.gov.
    • 01 Jan 2007 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 09 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top